• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不丹幽门螺杆菌的抗生素耐药率。

Antibiotics resistance rate of Helicobacter pylori in Bhutan.

机构信息

Ratha-korn Vilaichone, Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani 12120, Thailand.

出版信息

World J Gastroenterol. 2013 Sep 7;19(33):5508-12. doi: 10.3748/wjg.v19.i33.5508.

DOI:10.3748/wjg.v19.i33.5508
PMID:24023494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3761104/
Abstract

AIM

To survey the antibiotic resistance pattern of Helicobacter pylori (H. pylori) strains isolated from Bhutanese population.

METHODS

We isolated 111 H. pylori strains from the gastric mucosa of H. pylori-infected patients in Bhutan in 2010. The Epsilometer test was used to determine the minimum inhibitory concentrations (MICs) of amoxicillin (AMX), clarithromycin (CLR), metronidazole (MNZ), levofloxacin (LVX), ciprofloxacin (CIP), and tetracycline (TET).

RESULTS

Nineteen of the isolated H. pylori strains were susceptible to all antibiotics tested. The isolated strains showed the highest rate of antibiotic resistance to MNZ (92/111, 82.9%). Among the 92 MNZ-resistant strains, 74 strains (80.4%) showed high-level resistance (MIC ≥ 256 μg/mL). Three strains were resistance to LVX (2.7%). These strains were also resistance to CIP. None of the strains showed resistance to CLR, AMX and TET.

CONCLUSION

CLR-based triple therapy is a more effective treatment approach over MNZ-based triple therapy for H. pylori infection in Bhutan.

摘要

目的

调查从不丹人群中分离出的幽门螺杆菌(H. pylori)菌株的抗生素耐药模式。

方法

我们于 2010 年从不丹感染 H. pylori 的患者胃黏膜中分离出 111 株 H. pylori 菌株。采用 Epsilometer 试验测定阿莫西林(AMX)、克拉霉素(CLR)、甲硝唑(MNZ)、左氧氟沙星(LVX)、环丙沙星(CIP)和四环素(TET)的最小抑菌浓度(MIC)。

结果

19 株分离的 H. pylori 菌株对所有检测的抗生素均敏感。分离株对 MNZ 的耐药率最高(92/111,82.9%)。在 92 株 MNZ 耐药株中,74 株(80.4%)表现为高水平耐药(MIC≥256μg/ml)。3 株对 LVX(2.7%)耐药。这些菌株也对 CIP 耐药。没有菌株对 CLR、AMX 和 TET 表现出耐药性。

结论

对于不丹的 H. pylori 感染,CLR 为基础的三联疗法比 MNZ 为基础的三联疗法更有效。

相似文献

1
Antibiotics resistance rate of Helicobacter pylori in Bhutan.不丹幽门螺杆菌的抗生素耐药率。
World J Gastroenterol. 2013 Sep 7;19(33):5508-12. doi: 10.3748/wjg.v19.i33.5508.
2
Extremely High Prevalence of Metronidazole-Resistant Helicobacter pylori Strains in Mountain People (Karen and Hmong) in Thailand.泰国山区人群(克伦族和苗族)中甲硝唑耐药幽门螺杆菌菌株的极高流行率
Am J Trop Med Hyg. 2016 Apr;94(4):717-20. doi: 10.4269/ajtmh.15-0449. Epub 2016 Feb 15.
3
The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam.越南幽门螺杆菌原发性抗生素耐药率。
J Clin Gastroenterol. 2013 Mar;47(3):233-8. doi: 10.1097/MCG.0b013e3182676e2b.
4
Population-based study of Helicobacter pylori infection and antibiotic resistance in Bhutan.不丹基于人群的幽门螺杆菌感染和抗生素耐药性研究。
Int J Infect Dis. 2020 Aug;97:102-107. doi: 10.1016/j.ijid.2020.05.077. Epub 2020 May 29.
5
Antimicrobial-resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018-2020.日本的耐抗生素幽门螺杆菌:2018-2020 年全国监测报告。
Helicobacter. 2024 Jan-Feb;29(1):e13028. doi: 10.1111/hel.13028. Epub 2023 Oct 12.
6
Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing.建立幽门螺杆菌菌株抗菌药物敏感性测试参考面板。
Helicobacter. 2022 Jun;27(3):e12874. doi: 10.1111/hel.12874. Epub 2022 Mar 7.
7
Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China.常用抗生素对幽门螺杆菌最低抑菌浓度:华南地区多中心研究。
PLoS One. 2021 Sep 2;16(9):e0256225. doi: 10.1371/journal.pone.0256225. eCollection 2021.
8
Helicobacter pylori Multidrug Resistance Due to Misuse of Antibiotics in Iran.伊朗因抗生素滥用导致幽门螺杆菌出现多药耐药性。
Arch Iran Med. 2018 Jul 1;21(7):283-288.
9
High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam.越南东南部地区慢性胃炎患者幽门螺杆菌克拉霉素和左氧氟沙星耐药率较高。
J Glob Antimicrob Resist. 2020 Sep;22:620-624. doi: 10.1016/j.jgar.2020.06.007. Epub 2020 Jun 24.
10
Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.在西班牙北部,5 年内(2013-2017 年)幽门螺杆菌的抗菌药物耐药性及其与根除治疗的关系。
Helicobacter. 2019 Feb;24(1):e12557. doi: 10.1111/hel.12557. Epub 2018 Nov 20.

引用本文的文献

1
Efficacy and safety of low-dose tetracycline, amoxicillin quadruple therapy in infection: A retrospective single center study.低剂量四环素、阿莫西林四联疗法治疗感染的疗效和安全性:一项回顾性单中心研究。
World J Gastroenterol. 2024 Oct 21;30(39):4295-4304. doi: 10.3748/wjg.v30.i39.4295.
2
Drug Resistance Patterns of Commonly Used Antibiotics for the Treatment of Infection among South Asian Countries: A Systematic Review and Meta-Analysis.南亚国家治疗感染常用抗生素的耐药模式:系统评价与荟萃分析
Trop Med Infect Dis. 2023 Mar 14;8(3):172. doi: 10.3390/tropicalmed8030172.
3
Trends in antimicrobial consumption in Bhutan.不丹抗菌药物消费趋势。
IJID Reg. 2021 Oct 2;1:65-71. doi: 10.1016/j.ijregi.2021.09.009. eCollection 2021 Dec.
4
Efficacy of Omeprazole, Tetracycline, and 4 Times Daily Dosing of Amoxicillin in Helicobacter pylori Eradication in Limited Resource Area in Bhutan: A Prospective Randomized Trial (BHUTAN Study).在不丹资源有限地区,奥美拉唑、四环素和每日 4 次阿莫西林给药在幽门螺杆菌根除中的疗效:一项前瞻性随机试验(BHUTAN 研究)。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1109-1114. doi: 10.31557/APJCP.2020.21.4.1109.
5
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.台湾实施抗生素消费限制政策后幽门螺杆菌的原发性耐药性及其与毒力因子的关系——一项全国性研究
PLoS One. 2015 May 5;10(5):e0124199. doi: 10.1371/journal.pone.0124199. eCollection 2015.
6
Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance.大黄素、黄芩苷、五味子素和小檗碱对hefA基因的抑制作用:幽门螺杆菌诱导的多药耐药性的治疗
World J Gastroenterol. 2015 Apr 14;21(14):4225-31. doi: 10.3748/wjg.v21.i14.4225.
7
Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.应对幽门螺杆菌抗生素耐药性的合适一线治疗方案:亚洲视角
Molecules. 2015 Apr 8;20(4):6068-92. doi: 10.3390/molecules20046068.
8
Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?荟萃分析:四环素与阿莫西林联合使用适合治疗幽门螺杆菌感染吗?
World J Gastroenterol. 2015 Feb 28;21(8):2522-33. doi: 10.3748/wjg.v21.i8.2522.
9
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.广西少数民族患者幽门螺杆菌分离株:耐药率、耐药机制及基因型
World J Gastroenterol. 2014 Apr 28;20(16):4761-70. doi: 10.3748/wjg.v20.i16.4761.

本文引用的文献

1
Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain.西班牙目前使用的六种抗生素对幽门螺杆菌的药敏性。
J Antimicrob Chemother. 2012 Jan;67(1):170-3. doi: 10.1093/jac/dkr410. Epub 2011 Sep 29.
2
Epidemiology of Helicobacter pylori infection and public health implications.幽门螺杆菌感染的流行病学和公共卫生意义。
Helicobacter. 2011 Sep;16 Suppl 1(0 1):1-9. doi: 10.1111/j.1523-5378.2011.00874.x.
3
Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study.扩展病史揭示了幽门螺杆菌抗生素耐药的众多危险因素:一项保加利亚研究。
J Med Microbiol. 2012 Jan;61(Pt 1):85-93. doi: 10.1099/jmm.0.035568-0. Epub 2011 Aug 26.
4
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
5
Optimal therapy for Helicobacter pylori infections.幽门螺杆菌感染的最佳治疗方法。
Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):79-88. doi: 10.1038/nrgastro.2010.210.
6
Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia.马来西亚幽门螺杆菌分离株的抗生素敏感性模式分析。
Helicobacter. 2011 Feb;16(1):47-51. doi: 10.1111/j.1523-5378.2010.00816.x.
7
Second-line rescue therapy of helicobacter pylori infection.二线补救治疗幽门螺杆菌感染。
Therap Adv Gastroenterol. 2009 Nov;2(6):331-56. doi: 10.1177/1756283X09347109.
8
Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up.长期随访中 H. pylori 根除后萎缩性胃体胃炎的逆转。
Dig Liver Dis. 2011 Apr;43(4):295-9. doi: 10.1016/j.dld.2010.10.012. Epub 2010 Nov 27.
9
Management of Helicobacter pylori.幽门螺杆菌的管理
F1000 Med Rep. 2010 Mar 15;2:20. doi: 10.3410/M2-20.
10
Clinical practice. Helicobacter pylori infection.临床实践。幽门螺杆菌感染。
N Engl J Med. 2010 Apr 29;362(17):1597-604. doi: 10.1056/NEJMcp1001110.